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ABST RACT
According to World Health Organization (WHO), fetal death is defined as the
death of the fetus prior to its complete expulsion, independent of the duration of
pregnancy, thus only ascribing the term stillbirth to fetal deaths in the case of
pregnancies after 28 weeks of gestation. The great progress of perinatology care
is reflected in a significant reduction in the rate of stillbirths, especially in well developed countries, with approximately 98% of stillbirth cases now occurring in
poor and developing countries. Stillbirth powerfully impacts both the patient and
the practitioner. Because nearly half of stillbirth cases result from apparently
uncomplicated pregnancies, we considered it critical to review the known
predictive markers for intrauterine fetal death. In both preterm and term infants,
perinatal mortality is increased in fetuses small for their gestational age, and this
risk grows proportionally with the severity of the fetal growth restriction. A
protracted first stage of labor has not been associated with an increased risk of
perinatal mortality and morbidity, but a prolonged second stage of labor has been
associated with mortality and neonatal morbidity characterized by sepsis,
seizures, and hypoxic-ischemic encephalopathy. Ultrasound examination of the
placenta and the umbilical cord is essential for appropriate pregnancy monitoring.
Various findings from ultrasound examination have been related to variable
adverse perinatal outcomes, including intrauterine fetal death. After reviewing the
evidence for predictors of intrauterine fetal death, we offer a general strategy for
reducing the likelihood of stillbirths.

Introduction
The preferred term for intrauterine fetal death,
describing the in-utero death of a fetus after 24 weeks of
gestation, or at least 500 grams, is stillbirth. According
to the World Health Organization (WHO), fetal death is
defined as the death of the fetus prior to its complete
expulsion, independent of the duration of pregnancy,
ascribing the term stillbirth only to fetal deaths in case
of pregnancies after 28 weeks of gestation [1]. The limit
between miscarriage and stillbirth varies from country
to country, ranging between 16 and 28 weeks of
gestation [2-4]. Conversely, stillbirth can be “early” if it
occurs between 20 and 27 weeks of gestation and “late”
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if it complicates pregnancies with a gestational age
higher than 28 weeks. If the gestational age is unknown,
the second criterion that differentiates a miscarriage
from a stillbirth is the weight and the length if the first
two mentioned are unavailable (cut-off 25 cm).
The great progress of perinatology is reflected in the
significant reduction in the rate of stillbirths, especially
in developed countries, with approximately 98% of
stillbirth cases occurring in underdeveloped and
developing countries [5]. A number of fetal, maternal,
and placental factors correlate with the still birth rate,
including black race, extreme maternal age, marital
status, multiple gestations, and fetal sex [6,7].
According to McClure et al, the main factors responsible
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are prolonged labor, preeclampsia, and infectious
factors in developing countries, and congenital and
various karyotype anomalies in developed countries [8].
Stillbirth strongly impacts both the patient and the
practitioner, especially since nearly half of stillbirths
result from apparently uncomplicated pregnancies.
Stillbirth that occurs in early term is more likely to have
an obvious cause than one that occurs in late term [911]. Stillbirth that cannot be explained by an obvious
maternal, fetal, placental or obstetric factor has an
impressive incidence of 25 to 60%, with two thirds of
these cases occurring after 35 weeks of gestation. Given
its relatively high rate of unpredictability, we considered
it important to review the known predictive markers for
intrauterine fetal death.

Discussions
Fetal growth restriction and intrauterine fetal
death
A fetus diagnosed with fetal growth restriction,
meaning an estimated fetal weight below the 10th
percentile for its gestational age, implies a differential
diagnosis that distinguishes between a constitutionally
small fetus versus growth restriction from placental,
fetal, or maternal pathologies [12-15]. This
differentiation is important due to the associated adverse
perinatal outcomes, including preterm delivery,
impaired thermoregulation, impaired immune function,
perinatal asphyxia, hypoglycemia, diabetes, and

mortality. According to Zeitlin et al. [9], in both preterm
and term infants, perinatal mortality is increased in
fetuses small for their gestational age. This risk grows
proportionally with the severity of the fetal growth
restriction and shows a steep rise when fetal weight is
below the 6th percentile. In one recent study, researchers
examined more than 1.5 million singletons’ births and
found a significant difference in neonatal mortality
between term infants without fetal growth restriction
(0.6/1,000) and term infants with fetal growth restriction
(2.8/1,000), and a larger difference between preterm
infants with normal weight (22.9/1,000) and preterm
infants with fetal growth restriction (60.0/1,000) [16].
The authors concluded that methods that can detect and
prevent fetal growth restriction represent important
tools in decreasing fetal mortality.
In our unit, the Department of Obstetrics and
Gynecology, University Emergency Hospital Bucharest,
we conducted a retrospective study over a period of 5
years, January 2014 – October 2018, on 1405 preterm
infants and term infants with fetal growth restriction
[17-20]. The overall results agree with previously cited
results [10,21,22]. Table 1 lists the short-term
complications encountered in the studied population,
with the study group divided as follows: Group 1
consists of preterm newborns small for their gestational
age; Group 2 consists of preterm newborns appropriate
for their gestational age; and Group 3 consists of term
newborns small for their gestational age.

Table 1. The incidence of newborns in preterm and term newborns with intrauterine fetal growth restriction
[9].
Characteristic

Group 1

Group 2

Group 3

Total

P value

No.

%

No.

%

No.

%

No.

%

Total subjects

78

6%

1,121

80%

206

15%

1,405

100%

Males

37

3%

573

41%

85

6%

695

49%

0.032

Demise

14

18%

51

5%

2

1%

67

5%

<0.001

The shaded row of the table highlights the differences
in perinatal mortality among the three groups, with the
highest percentage corresponding to the preterm infants
with growth restriction. No difference was found between
term infants with fetal growth restriction and preterm
infants with a weight appropriate for their gestational age.
We developed a management protocol for complicated
cases with fetal growth restriction that includesd: (1) serial
ultrasound evaluation, biophysical profile, and Doppler
velocimetry (from one to seven times per week) for guiding

the subsequent pregnancy management; (2) administering
antenatal corticosteroids for pregnancies from 24 to 34
weeks of gestation; and (3) executing immediate delivery
of fetuses with abnormal ductus venosus Doppler flow
rates prior to 32 weeks gestation, reversed diastolic flow
of the umbilical artery at a gestational age greater than 32
weeks, or absent diastolic flow of the umbilical artery at
the gestational age over 34 weeks. In order to prolong the
duration of pregnancy over 32 weeks gestation, daily
biophysical profiles were recommended, and delivery was
53
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imposed only by reversed diastolic flow of the umbilical
artery associated with an abnormal biophysical profile.
Prolonged labor and fetal death
Conventionally, labor abnormalities are described as
protraction disorders or arrest disorders. An abnormally
long active phase is called protracted, and an abnormally
long latent phase is described as prolonged [23]. Regarding
effects on the mother, these disorders are associated with
an increased risk of postpartum hemorrhage, operative
vaginal delivery, caesarean delivery, third or fourth degree
perineal lacerations, and chorioamniotitis [24, 25]. As for
the neonate, a protracted first stage of labor has not been
associated with an increased risk of perinatal mortality and
morbidity, whereas a prolonged second stage of labor has
been associated with mortality and neonatal morbidity that
can includes sepsis, seizures, and hypoxic-ischemic
encephalopathy [26,27]. Usually, a prolonged second
phase of labor is associated with fetal macrosomia or
persistent malposition, thus increasing the risk of perinatal
mortality and morbidity. The duration of the second phase
is considered prolonged if a nulliparous woman has pushed
for three hours or a multiparous woman has pushed for two
hours, in the absence of epidural anesthesia, with a
minimum or absent progression [28].
Augmentation with oxytocin is indicated after 60-90
minutes of pushing if birth progression is minimal or
absent, and the uterine contractions have a frequency of
less than 1 to 3 minutes, considering the fact that the main
causes of prolonged second phase are macrosomia, a small
maternal pelvis, and malposition or malpresentation, but
not hypocontractility specifically during the first phase of
labor. Extending these intervals is allowed only if a safe
vaginal delivery is achievable from an obstetrical point of
view, assessed by careful weighing of the risks and benefits
that take into account obstetrical history, clinical
pelvimetry, maternal height and weight, fetal position,
surgical history, estimated fetal weight, fetal heart rate, and
the patient’s consent after understanding the risks of
prolonging labor [29-32].
Interventions have been aimed at preventing the
prolongation of labor, such as delayed pushing, changed
maternal position, and pelvic floor muscle exercises. None
of these interventions appears to affect the length of the
second phase [18, 33].
Pathology and intrauterine fetal death
Ultrasonic examination of the placenta and the
umbilical cord is essential for appropriate pregnancy
monitoring. Multiple findings on sonographic examination
can be related to adverse perinatal outcomes, including
54

intrauterine fetal death. Here we discuss the particular
ultrasound aspects of the umbilical cord and the placenta,
along with their association with poor perinatal prognosis.
1. Single umbilical artery - This diagnosis is based on the
visualization of a single vessel around the fetal bladder,
occurring in about 0.5% of pregnancies. This characteristic
has been associated with maternal diabetes, smoking, and
seizure disorders [34, 35]. The outcome of such cases is
influenced by the associated conditions. Single umbilical
artery without other anomalies does not demonstrate a
statistically significant increase in fetal, neonatal, and
infant death [20], but results in an increased risk when
associated with anatomical and chromosomal anomalies.
Recommended antepartum fetal monitoring, in the absence
of other associated conditions, involves following fetal
growth every 4-6 weeks, as there is a significant
association between single umbilical artery and
intrauterine growth restriction. A postnatal renal screening
of infants should also be considered if the kidneys were
poorly visualized on prenatal ultrasound [36, 37].
2. Hypoplasia of one umbilical artery may occasionally
be diagnosed during ultrasound screening. There is no
standard definition for the disparity between the sizes of
the umbilical arteries. This condition has a higher
prevalence in the high-risk population, and thus screening
for other fetal anomalies should be performed.
3. Aneurysm and varix of the umbilical cord have a low
incidence, but they are also highly associated with fetal
demise through rupture, intra-amniotic hemorrhage, and
fetal exsanguination [21, 38]. If this abnormality is
diagnosed prenatally, frequent fetal monitoring with nonstress testing, ultrasound, and delivery after lung
maturation are indicated [22, 23].
4. Velamentous cord insertion has a prevalence of 1% in
singleton pregnancies, and it can be diagnosed through
prenatal ultrasound examination by observing the
umbilical cord insertion several centimeters from the
placenta at the point where the umbilical vessels divide
[39]. Fetal death can occur when fetal membranes rupture,
which can lead to the rupture of the umbilical vessels,
especially in the case of vasa previa [25, 40]. Considering
these complications, if the ultrasound examination
suggests velamentous cord insertion, a detailed ultrasound
screening is required for the evaluation of coexisting vasa
previa. Moreover, serial assessment of fetal growth,
weekly non-stress testing after 36 weeks of gestation, and
delivery at 40 weeks of gestation are also recommended.
Specifically, these cases require continuous intrapartum
fetal heart monitoring [41-43].
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5. True knot in the cord is associated with a high risk of
fetal demise if the knot is tight or multiple [44, 45]. These
pregnancies require close monitoring particularly in the
last trimester, with serial ultrasound examinations that
include Doppler evaluation, assessment of fetal growth,
determining amniotic fluid index, biophysical profile
scoring, and non-stress testing.
6. Abruptio placentae affects about 1% of pregnancies,
with the sensitivity of a prenatal ultrasound for this
condition at only 25-60% [27, 46]. Chronic abruption is
associated with a high risk for fetal growth restriction and
all the consequences of this pathology, whereas acute
abruption has a perinatal mortality of 3 to 12%, with more
that 50% of these cases ending in stillbirth [47]. The
diagnosis is mainly clinical, and the details of management
include continuous fetal monitoring, secure intravenous
access, monitoring the maternal hemodynamic status, and
evaluating for coagulopathy [48, 49]. Subsequent medical
decisions will depend on fetal and maternal status.
Immediate delivery is recommended if the fetal heart rate
pattern is non-reassuring or ominous. If the mother and the
fetus are stable, but an abruption placenta is suspected,
delivery is suggested for pregnancies after 34 weeks of
gestation, as the benefits of delivery at this time surpass the
risks. Because the risk of recurrence of this pathology (315%) is common, a subsequent pregnancy for the patient
should be considered a high-risk pregnancy.
7. Placenta previa is associated with a 3-5 times
increased risk of preterm birth [50, 51]; thus perinatal and
neonatal morbidity and mortality are directly related to
prematurity complications. In order to reduce neonatal
morbidity and mortality rates, the administration of
antenatal corticosteroids before 34 weeks of gestation is
recommended for all placenta previa cases, and planned
late preterm cesarean delivery should be considered.
Several characteristics appear predictive of antepartum
bleeding, including a cervical length less than 3
centimeters, and a decrease in cervical length in the last
trimester, as well as a thick placental edge with echo free
space over the internal os [52].
Post-term pregnancy
A post-term pregnancy may be associated with
continued fetal growth with a subsequent birth of a large
fetus, or a poorly functional placenta, resulting in fetal
growth restriction and a small malnourished fetus for the
gestational age [53]. A recent study [54] regarding the
incidence of stillbirths in post-term pregnancies has
indicated a twofold increase compared to term pregnancies.
Factors that increase perinatal mortality incidence are feto-

placental insufficiency, asphyxia, intrauterine infection,
primigravidity, and older maternal age [55]. For singleton,
cephalic, uncomplicated pregnancies, the induction of
labor at 41 weeks gestation, irrespective of the cervical
status, is recommended in the context of a well predefined
gestational age and a reassuring fetal assessment. This
approach offers a 70% reduction in perinatal mortality and
stillbirth [56]. Each decision must be adapted to the
individual case, with the maternal perception of decreased
fetal movement considered a marker for increased risk of
fetal death [57].
Gestational diabetes
Pregnancies involving gestational diabetes require
monitoring and treatment of the conditions associated with
glucose impairment. The risk of stillbirth associated with
gestational diabetes is higher than in the general
population, and it is primarily related to poor glycemic
control [58]. The presence of polyhydramnios appears to
be an important marker for an increased stillbirth risk in all
non-anomalous pregnancies with or without gestational
diabetes [59]. Good glycemic control is the essential point
in the management of these cases. Antenatal fetal testing
includes non-stress testing twice a week and ultrasound
examination of the amniotic fluid beginning at 32 weeks of
gestation for all women with a poor glycemic control or
treatment with insulin or oral anti-hyperglycemic drugs.
Optimal timing of delivery for pregnancies with gestational
diabetes may help avoid possible complications, including
stillbirth. After discussing the risks and benefits with the
patient, a recommended approach is to induce labor for
euglycemic women after 39 weeks gestation, and for
women with medically controlled gestational diabetes at 39
weeks gestation. For women with poor glycemic control,
delivery at 37+0 - 38+6 weeks gestation is considered
reasonable [38, 60].
Infections
Infection is responsible for one half of stillbirths in
developing countries and 10 to 25% in developed countries
[61, 62]. The effect is mediated through severe systemic
maternal illness, placental infection, and placental
dysfunction, or through fetal systemic illness. Most cases
cause premature birth due to preterm premature rupture of
membranes. Trans-placental infection is caused mostly by
viral pathogens and less frequently by bacteria, fungi,
spirochetes, and protozoa. Fetal death due to infection is
not common, even though almost all systemic infections
that occur during pregnancy can cause placental infection.
In endemic areas, malaria is a common cause of stillbirth.
Well-known maternal infections that can lead to fetal
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demise
include
cytomegalovirus,
parvovirus,
toxoplasmosis, listeria, and herpes simplex virus [63, 64].
Asymptomatic maternal vaginal infections are highly
frequent, therefore, successive screening for urinary and
genital infection during pregnancy is mandatory.
It is important to mention infection with Group B
streptococcus, which is a frequent cause of asymptomatic
bacteriuria, as well as urinary tract infection and upper
genital tract infection. Data from Centers for Disease
Control and Prevention (USA) indicate a 0.12 per 1000 live
births rate of infection with Group B streptococcus, which
can lead to adverse outcomes such as neonatal infections,
fetal death, neonatal death, and pregnancy loss for 50% of
cases [52, 65].

as they lead to increased monitoring and care. As an
example, an audit from Northern Ireland reported that the
most common error leading to intrauterine fetal death was
failure in diagnosing and appropriately managing cases
with intrauterine growth restriction.
On a final note, as a practitioner, it may be difficult to
choose an appropriate way to react to and communicate
with the parents after the birth of a stillborn child. Several
key points described in this article may offer grieving
parents explanation of the situation, which may support
them during their bereavement.
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Based on this review, we formulated a prevention
strategy for stillbirth that involves 10 basic interventions:
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1. Periconceptional supplementation with folic acid
2. Prevention of malaria in endemic areas
3. Screening for and treatment of syphilis
4. Detection, prevention, and treatment of hypertensive
disorders of pregnancy
5. Detection and appropriate management of gestational
diabetes
6. Screening, monitoring, and management of
pregnancies complicated with intrauterine growth
restriction
7. Identification and induction of post-term pregnancies
8. Delivery in a specialized unit assisted by a skilled birth
attendant
9. Capacity for possible basic emergency obstetric care
10. Capacity for possible comprehensive emergency
obstetric care.
Although no research trials have demonstrated an
effective method for reducing stillbirth rates in the general
population, the above strategies are generally applicable
and important. By identifying conditions that increase the
risk of stillbirth, its occurrence can be reduced through an
appropriate obstetrical approach, as management with
suboptimal care is responsible for 10 to 60% of perinatal
deaths. Interventions to lower modifiable risk factors, the
prevention of obesity or encouragement of weight
reduction, the avoidance of pregnancies at extreme
maternal age, smoking cessation, and alcohol and
recreational drug abstinence could reduce the number of
stillbirths. Antenatal fetal monitoring that identifies fetuses
with intrauterine growth restriction or fetuses with nonreassuring status are key strategies for stillbirth reduction,
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